Polyurethane Male Condoms with Different Size and Thickness in Healthy Couples
Polyurethane (PU) male condom-Test condom 1
+ Polyurethane (PU) male condom-Test condom 2
+ Natural Rubber Latex (NRL) male condom- Control condom
Prevention Study
Summary
Study start date: August 23, 2024
Actual date on which the first participant was enrolled.This study is designed to compare the performance of two new types of polyurethane (PU) male condoms with different sizes and thickness against a widely-used thin latex male condom. The focus is on healthy couples who are in a monogamous relationship and engage in vaginal intercourse. The goal is to understand how these new PU condoms perform in real-life situations and to see if they are a good alternative to latex condoms. This is important because it could provide more options for people who are allergic to latex or prefer different condom materials. Participants in this study will use each type of condom during vaginal intercourse and provide feedback on their experiences. The study will evaluate how well each condom performs and how comfortable they are to use. There are no specific risks mentioned, but the benefits could include finding a new condom material that offers the same or better protection and comfort as current options. Participants' experiences will help researchers determine the in-use tolerance and overall effectiveness of these new PU condoms.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.600 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 60 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalGroup III
Active ComparatorStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 3 locations
Essential Access Health-Berkeley
Berkeley, United StatesOpen Essential Access Health-Berkeley in Google MapsEssential Access Health -Los Angeles
Los Angeles, United StatesEssential Acess Health- Seattle
Seattle, United States